tradingkey.logo
搜索

MiMedx Group Inc

MDXG
添加自选
3.680USD
+0.070+1.94%
收盘 06/18, 16:00美东报价延迟15分钟
546.63M总市值
17.71市盈率 TTM

关于 MiMedx Group Inc 公司

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

MiMedx Group Inc简介

公司代码MDXG
公司名称MiMedx Group Inc
上市日期Aug 20, 2007
CEOCapper (Joseph H)
员工数量837
证券类型Ordinary Share
年结日Aug 20
公司地址1775 W Oak Commons Court, Ne
城市MARIETTA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编30062
电话17706519100
网址https://mimedx.com/
公司代码MDXG
上市日期Aug 20, 2007
CEOCapper (Joseph H)

MiMedx Group Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
--
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
--
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
--
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
--

常见问题

MiMedx Group Inc的前五大股东是谁?

MiMedx Group Inc 的前五大股东如下:Mr. Joseph H. (Joe) Capper

有多少机构持有MiMedx Group Inc(MDXG)的股份?

截至2026Q1,共有462家机构持有MiMedx Group Inc的股份,合计持有的股份价值约为116.77M,占公司总股份的78.40%。与2025Q4相比,机构持股有所增加,增幅为6172968.00。

哪个业务部门对MiMedx Group Inc的收入贡献最大?

在2026Q1,Advanced Wound Care业务部门对MiMedx Group Inc的收入贡献最大,创收276.33M,占总收入的66.01%。
KeyAI